Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Denali Therapeutics Inc
About DNLI
Denali Therapeutics Inc. is a biopharmaceutical company establishing a new class of biotherapeutics designed to cross the blood-brain barrier using its TransportVehicle platform. It is focused on building a portfolio of therapeutic candidates by investing in its TV franchises, i.e., Enzyme TV (ETV), Oligonucleotide TV (OTV), and Antibody TV (ATV), to advance programs for rare diseases, such as lysosomal storage diseases, and common diseases, such as Alzheimer's disease and Parkinson's disease. Its most advanced TV-enabled program is tividenofusp alfa (DNL310, ETV:IDS) for the potential treatment of mucopolysaccharidosis II (Hunter syndrome). TV-enabled clinical development portfolio also includes DNL126 (ETV:SGSH) for mucopolysaccharidosis IIIA (Sanfilippo syndrome type A), DNL593 (PTV:PGRN) for frontotemporal dementia-granulin, DNL628 (OTV:MAPT) for Alzheimer’s disease, and DNL952 (ETV:GAA) for Pompe disease. It is also pursuing opportunities in other disease areas including oncology.
Find out what a historical investment in Denali Therapeutics Inc would be worth today using our DNLI stock calculator.
Market Capitalisation
$2.87B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.38M
High today
$19.18
Low today
$18.11
Open price
$18.21
52-week high
$23.77
52-week low
$12.58
Ready to start your investing journey with Stake?
Open an accountHow do I buy DNLI shares in Australia?
Buying DNLI shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Denali Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DNLI
What is the ticker symbol of Denali Therapeutics Inc?
The ticker symbol for Denali Therapeutics Inc is DNLI.
How much is one share of DNLI?
One share of DNLI is valued at $18.88 as of 20 May 2026.
What is the market capitalisation of Denali Therapeutics Inc DNLI?
As of 20 May 2026 Denali Therapeutics Inc has a market cap of $2.87B.
What is the 52-week high for Denali Therapeutics Inc stock?
The Denali Therapeutics Inc 52-week high stock price is $23.77.
What is the 52-week low for Denali Therapeutics Inc stock?
The Denali Therapeutics Inc 52-week low stock price is $12.58.
Can I buy DNLI shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DNLI shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DNLI on Stake
- Buy DNLI from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of DNLI from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
DNLI related stocks